# Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

> **NCT05123001** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 11 (actual)

## Conditions studied

- Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Leukemia
- Multiple Myeloma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05123001
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-15
- **Primary completion:** 2022-07-07
- **Final completion:** 2022-07-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05123001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05123001, "Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05123001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*